PALOPEGTERIPARATIDE
UNII G2N64C3385

Substance Identification & Data

This profile provides standardized clinical and technical data for Palopegteriparatide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G2N64C3385.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2222514-07-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G2N64C3385

CAS Registry Number

2222514-07-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PALOPEGTERIPARATIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

G2N64C3385

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C179112

National Cancer Institute reference terminology for clinical and research data.

INN ID

11060

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-104

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Palopegteriparatide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PALOPEGTERIPARATIDE

Common Names & Synonyms

MPEG 40000-TERIPARATIDE

PALOPEGTERIPARATIDE [INN]

PALOPEGTERIPARATIDE [USAN]

PALOPEGTERIPARATIDE [WHO-DD]

TRANSCON PARATHYROID HORMONE (1-34)

TRANSCON PTH (1-34)

Brand / Trade Names

YORVIPATH

Systematic Nomenclature

HUMAN PARATHYROID HORMONE (PTH) SYNTHETIC PEPTIDE FRAGMENT (1-34), CONJUGATED AT THE N-TERMINAL AMINO GROUP VIA A CLEAVABLE LINKER TO O-METHYLPOLYETHYLENE GLYCOL (2 X 20 KDA MPEG); 2-METHYLALANYL-(1-34)-PEPTIDE OF PARATHYROID HORMONE (HOMO SAPIENS PARATHYRIN, PARATHORMONE, PTH) CONJUGATED WITH O-METHYLPOLYETHYLENE GLYCOL VIA A CLEAVABLE LINKER AT THE N-TERMINAL AMINO GROUP: N-((2-((6-(((3RS)-1-(3-((3-((2.XI.)-2,3-BIS(.ALPHA.METHYLPOLY(OXYETHYLENE)-.OMEGA.-OXY)PROPOXY)PROPYL)AMINO)-3- OXOPROPYL)-2,5-DIOXOPYRROLIDIN-3- YL)SULFANYL)HEXYL)AMINO)ETHYL)CARBAMOYL)-2-METHYLALANYL-LSERYL-L-VALYL-L-SERYL-L-.ALPHA.-GLUTAMYL-L-ISOLEUCYL-L-GLUTAMINYL-LLEUCYL-L-METHIONYL-L-HISTIDYL-L-ASPARAGINYL-L-LEUCYLGLYCYL-LLYSYL-L-HISTIDYL-L-LEUCYL-L-ASPARAGINYL-L-SERYL-L-METHIONYL-L.ALPHA.-GLUTAMYL-L-ARGINYL-L-VALYL-L-.ALPHA.-GLUTAMYL-L-TRYPTOPHYL-LLEUCYL-L-ARGINYL-L-LYSYL-L-LYSYL-L-LEUCYL-L-GLUTAMINYL-L-.ALPHA.ASPARTYL-L-VALYL-L-HISTIDYL-L-ASPARAGINYL-L-PHENYLALANINE

SYS

POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-HYDRO-.OMEGA.-METHOXY-, ETHER WITH N-(((2-((6-((1-(3-((3-(2,3-DIHYDROXYPROPOXY)PROPYL)AMINO)-3-OXOPROPYL)-2,5-DIOXO-3-PYRROLIDINYL)THIO)HEXYL)AMINO)ETHYL)AMINO)CARBONYL)-2-METHYLALANYL-L-SERYL-L-VALYL-L-SERYL-L-.ALPHA.-GLUTAMYL-L-ISOLEUCYL-L-GLUTAMINYL-L-LEUCYL-L-METHIONYL-L-HISTIDYL-L-ASPARAGINYL-L-LEUCYLGLYCYL-L-LYSYL-L-HISTIDYL-L-LEUCYL-L-ASPARAGINYL-L-SERYL-L-METHIONYL-L-.ALPHA.-GLUTAMYL-L-ARGINYL-L-VALYL-L-.ALPHA.-GLUTAMYL-L-TRYPTOPHYL-L-LEUCYL-L-ARGINYL-L-LYSYL-L-LYSYL-L-LEUCYL-L-GLUTAMINYL-L-.ALPHA.-ASPARTYL-L-VALYL-L-HISTIDYL-L-ASPARAGINYL-L-PHENYLALANINE (2:1)

SYS